Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
By How Much Is The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Expected To Expand Between 2025 And 2029?
The advanced therapy medicinal products contract development and manufacturing organization (cdmo) market size has observed swift growth in recent years. It is anticipated to expand from $5.31 billion in 2024 to $6.2 billion in 2025, achieving a compound annual growth rate (CAGR) of 16.7%. This historical growth can be ascribed to an escalating number of ATMP clinical trials, enhanced awareness and confidence among researchers regarding the advantages of advanced therapy, the existence of multiple ATMP CDMOs, intensifying efforts to create novel treatments for various diseases, and encouraging government policies.
The market for advanced therapy medicinal products contract development and manufacturing organizations (CDMOs) is projected to experience swift expansion in the upcoming years. By 2029, this market is anticipated to reach “$11.12 billion, demonstrating a compound annual growth rate (CAGR) of 15.7%. This projected growth during the forecast period stems from substantial investments made by CDMOs, an expanding presence of new entrants in the cell and gene therapy (CGT) industry, rising financial support and funding for cell and gene therapy advancements, an uptick in pharmaceutical research and development expenditures, and a greater number of clinical trials involving ATMPs. Key trends anticipated during this period encompass enhancements in AAV biomanufacturing facilities, the broadening of cell and gene therapy production capabilities, technological progress within cell and gene therapy, a rising demand for sophisticated platforms and technologies, and the integration of advanced methods like CRISPR and next-generation sequencing to achieve improved precision.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15719&type=smp
Which Drivers Are Shaping The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Industry’s Market Share?
The growing count of clinical trials is anticipated to boost the expansion of the advanced therapy medicinal products CDMO market moving forward. Clinical trials are investigative studies performed on humans to assess the safety and effectiveness of medical interventions such as drugs, therapies, devices, or preventative measures. The volume of clinical trials is increasing to satisfy the rising demand for innovative treatments and to tackle a growing global disease burden. With the adoption of advanced therapy medicinal products, the need for CDMO manufacturing services escalates, leveraging specialized expertise and infrastructure. Data from clinical trials helps in optimizing manufacturing, ensuring scalability, and maintaining quality to meet larger clinical and commercial requirements. For instance, in November 2023, according to the Association of the British Pharmaceutical Industry, a UK-based trade association, the total number of industry clinical trials initiated in the UK annually showed a marginal rise of 4.3%, from 394 in 2021 to 411 in 2022. Thus, the increasing number of clinical trials is propelling the growth of the advanced therapy medicinal products CDMO market.
What Are The Primary Types Of Segments Analyzed In The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
The advanced therapy medicinal products contract development and manufacturing organization (cdmo)market covered in this report is segmented –
1) By Product: Gene Therapy; Cell Therapy; Tissue Engineered
2) By Phase: Phase I; Phase II; Phase III; Phase IV
3) By Indication: Oncology; Cardiology; Central Nervous System And Musculoskeletal; Infectious Disease; Dermatology; Endocrine, Metabolic, Genetic; Immunology And Inflammation; Ophthalmology; Hematology
Subsegments:
1) By Gene Therapy: Viral Vectors; Non-Viral Vectors; Dna Or Rna-Based Products
2) By Cell Therapy: Autologous Cell Therapy; Allogeneic Cell Therapy; Stem Cell Therapy
3) By Tissue Engineered: Skin Substitutes; Cartilage And Bone Tissue; Vascular Grafts And Organs
Which Ongoing Trends Are Expected To Shape The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Outlook?
Leading companies operating within the advanced therapy medicinal products CDMO market are developing advanced cell therapy manufacturing services. This initiative aims to resolve critical issues in cell therapy production and expedite their partners’ development activities. Cell therapy manufacturing services are offerings from contract development and manufacturing organizations that range from early preclinical development to late-stage clinical trials and commercialization. For instance, in January 2024, Pluristem Therapeutics Inc., an Israel-based biotech firm specializing in transforming cells into solutions, launched PluriCDMO, a new business division dedicated to cell therapy manufacturing. This division utilizes a patented bioreactor system that facilitates 3D cell multiplication, enabling the production of various cell types such as stem cells, induced pluripotent stem cells, exosomes, and immune therapies. PluriCDMO intends to supply high-quality, vital medicines to patients, ensuring exceptional batch-to-batch consistency through scalable and cost-effective approaches within good manufacturing practice settings.
Who Are The Major Companies Operating In The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
Major companies operating in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) market are Thermo Fisher Scientific Inc., Merck KGaA, Resonac Corporation, Lonza Group AG, Catalent Inc., Charles River Laboratories International Inc., Recipharm AB, KBI Biopharma, Takara Bio Inc., Rentschler Biopharma SE, Ajinomoto Co. Inc., ElevateBio LLC, Fujifilm Diosynth Biotechnologies, Axplora Group GmbH, WuXi Advanced Therapies Inc., Celonic Group, Batavia Biosciences B.V., BioCentriq, Cytovance Biologics, Andelyn Biosciences, Genezen, AGC Biologics, ABL Manufacturing, Minaris Regenerative Medicine, Porton Advanced Solutions
Download The Full Report For Exclusive Market Findings:
What Are The Key Regional Factors Influencing The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Growth?
North America was the largest region in the advanced therapy medicinal product contract development and manufacturing organization (CDMO) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report:
https://www.thebusinessresearchcompany.com/customise?id=15719&type=smp
Browse Through More Reports Similar to the Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market 2025, By The Business Research Company
Advanced Therapeutics Pharmaceutical Outsourcing Global Market Report 2025
Advanced Ceramics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/advanced-ceramics-global-market-report
Advanced Biofuels Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/advanced-biofuels-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model